French startup Solence, an innovative app focused on supporting women with Polycystic Ovary Syndrome (PCOS), has successfully secured €1.6 million in Seed funding. This investment, led by Impact Shakers Ventures, includes prominent angel investors like Céline Lazorthes and Berthe Latreille. Founded by Clara Stephenson in 2022, Solence addresses a significant gap in women’s healthcare, aiming to enhance life expectancy by leveraging data for personalized, AI-driven solutions to manage PCOS—a condition affecting 1 in 7 women globally. The app emphasizes lifestyle interventions over traditional pharmacotherapy, offering a 12-week program rooted in peer-reviewed research. Clara, diagnosed with PCOS herself, aims to provide women with resources and community support, acknowledging that over 85% of sufferers experience reduced quality of life. With future plans to expand clinical partnerships and strengthen distribution, Solence is poised to transform PCOS care and improve the well-being of millions.
Source link
